Trial Profile
Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Ibutamoren (Primary)
- Indications Muscle weakness
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 06 Jun 2014 New trial record